- Home
- PALI vs SD Comparison
PALI vs SD Comparison
Compare PALI & SD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PALI
- SD
- Stock Information
- Founded
- PALI 1996
- SD 2006
- Country
- PALI United States
- SD United States
- Employees
- PALI 8
- SD N/A
- Industry
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- SD Oil & Gas Production
- Sector
- PALI Health Care
- SD Energy
- Exchange
- PALI Nasdaq
- SD Nasdaq
- Market Cap
- PALI 3.1M
- SD N/A
- IPO Year
- PALI N/A
- SD 2007
- Fundamental
- Price
- PALI $0.67
- SD $11.45
- Analyst Decision
- PALI Strong Buy
- SD
- Analyst Count
- PALI 2
- SD 0
- Target Price
- PALI $23.00
- SD N/A
- AVG Volume (30 Days)
- PALI 703.8K
- SD 358.8K
- Earning Date
- PALI 03-24-2025
- SD 05-06-2025
- Dividend Yield
- PALI N/A
- SD 3.85%
- EPS Growth
- PALI N/A
- SD 3.05
- EPS
- PALI N/A
- SD 1.69
- Revenue
- PALI N/A
- SD $125,290,000.00
- Revenue This Year
- PALI N/A
- SD $37.50
- Revenue Next Year
- PALI N/A
- SD $5.17
- P/E Ratio
- PALI N/A
- SD $6.75
- Revenue Growth
- PALI N/A
- SD N/A
- 52 Week Low
- PALI $0.64
- SD $10.31
- 52 Week High
- PALI $9.65
- SD $15.31
- Technical
- Relative Strength Index (RSI)
- PALI 31.54
- SD 48.47
- Support Level
- PALI $0.64
- SD $11.17
- Resistance Level
- PALI $0.73
- SD $11.58
- Average True Range (ATR)
- PALI 0.07
- SD 0.28
- MACD
- PALI 0.00
- SD 0.02
- Stochastic Oscillator
- PALI 6.48
- SD 44.00
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.